Achieve life sciences to present at h.c. wainwright bioconnect virtual conference

Seattle, wash, jan. 06, 2022 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that john bencich, chief executive officer, will give a presentation at the h.c. wainwright bioconnect virtual conference. the conference is taking place virtually from january 10 - 13, 2022. details for access to the presentation are as follows:
ACHV Ratings Summary
ACHV Quant Ranking